Clinical trials
Completed Lung Diseases trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 7 |
| Bayer | 3 |
| Novartis Pharmaceuticals | 3 |
| Istituti Clinici Scientifici Maugeri SpA | 2 |
| Consorcio Centro de Investigación Biomédica en Red (CIBER) | 1 |
| Debiopharm International SA | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Hoffmann-La Roche | 1 |
| IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 1 |
| Leiden University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 31 |
| Respiratory Tract Diseases | 10 |
| Pulmonary Disease, Chronic Obstructive | 9 |
| Asthma | 5 |
| Bronchial Diseases | 5 |
| Cardiovascular Diseases | 5 |
| Neoplasms | 5 |
| Cystic Fibrosis | 4 |
| Lung Diseases, Obstructive | 4 |
| Carcinoma | 3 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.